Adverse GI effects (nausea, vomiting, anorexia and diarrhoea) caused by azathioprine may be minimized by giving the drug in divided doses and/or after meals.
Hepatoxicity may occur in patients receiving azathioprine principally in allograft patients. Rare, but life-threatening hepatic veno-occlusive disease has occurred during chronic azathioprine therapy.






